EP3558955
Bensísóþíasól, ísóþíasóló[3,4-b]pýridín, kínasólín, þalasín, pýridó[2,3-d]pýridasín og pýridó[2,3-d]pýrimídín afleiður sem KRAS G12C hindrar til meðhöndlunar á krabbameini í lungum, brisi eða ristli og endaþarmi
:
EP einkaleyfi í gildi á Íslandi:
21.12.2017:
11.8.2021:
17832646.8
:
21.10.2021:
15.11.2021
:
20.12.2037:
20.12.2025:
31.12.2025
:
BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER
21.12.2017
11.8.2021
21.10.2021
15.11.2021
20.12.2025
:
Amgen Inc.:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
:
LANMAN, Brian Alan:
Woodland Hills, California 91367, US
:
CEE, Victor J.:
Thousand Oaks, California 91362, US
:
PICKRELL, Alexander J.:
Westlake Village, California 91361, US
:
REED, Anthony B.:
Newbury Park, California 91320, US
:
YANG, Kevin C.:
San Gabriel, California 91775, US
:
KOPECKY, David John:
Washington, District of Columbia 20005, US
:
WANG, Hui-Ling:
Thousand Oaks, California 91360, US
:
LOPEZ, Patricia:
Woodland Hills, California 91367, US
:
ASHTON, Kate:
Westlake Village, California 91361, US
:
BOOKER, Shon:
Sherman Oaks, California 91403, US
:
TEGLEY, Christopher M.:
Daly City California 94015, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201662438334 P:
22.12.2016:
US
:
US2017067801:
21.12.2017
:
C07D 275/04, C07D 417/04, C07D 471/08, C07D 513/04, C07D 487/10, C07D 487/04, C07D 239/80, C07D 471/04, C07D 401/04, C07D 403/04, A61K 31/428, A61K 31/429, A61K 31/437, A61K 31/517, A61K 31/519, A61K 31/498, A61K 31/4985, A61P 35/00
: 5
: 26.11.2021
: 20.12.2022
: Árnason Faktor ehf.
: 6
: 22.11.2022
: 20.12.2023
: Árnason Faktor ehf.
: 7
: 12.12.2023
: 20.12.2024
: Árnason Faktor ehf.
: 8
: 28.11.2024
: 20.12.2025
: Árnason Faktor ehf.